CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-01 | Mancini Marianna Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −51,000 | 153,000 | ||
| 2024-03-27 | Mancini Marianna Chief Operating Officer | Grant or award | +31,667 | 380,175 | ||
| 2024-03-27 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −16,610 | $83.34 | $1.4M | 363,565 |
| 2024-03-27 | Lian Brian President & CEO | Grant or award | +221,667 | 2,420,401 | ||
| 2024-03-27 | Lian Brian President & CEO | Shares withheld for taxes | −153,948 | $83.34 | $12.8M | 2,266,453 |
| 2024-03-27 | ZANTE GREG Chief Financial Officer | Grant or award | +31,667 | 223,971 | ||
| 2024-03-27 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −16,610 | $83.34 | $1.4M | 207,361 |
| 2024-03-01 | Lian Brian President & CEO | Grant or award | +221,667 | 2,361,549 | ||
| 2024-03-01 | Lian Brian President & CEO | Shares withheld for taxes | −162,815 | $85.22 | $13.9M | 2,198,734 |
| 2024-03-01 | Mancini Marianna Chief Operating Officer | Grant or award | +31,667 | 365,466 | ||
| 2024-03-01 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −16,958 | $85.22 | $1.4M | 348,508 |
| 2024-03-01 | ZANTE GREG Chief Financial Officer | Grant or award | +31,667 | 212,397 | ||
| 2024-03-01 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −20,093 | $85.22 | $1.7M | 192,304 |
| 2024-02-09 | Lian Brian President & CEO | Sale 10b5-1 | −45,000 | $29.90 | $1.3M | 2,139,882 |
| 2024-02-08 | Lian Brian President & CEO | Option exercise 10b5-1 | +49,079 | $1.23 | $60K | 2,313,961 |
| 2024-02-08 | Lian Brian President & CEO | Sale 10b5-1 | −49,079 | $25.75 | $1.3M | 2,264,882 |
| 2024-02-08 | Lian Brian President & CEO | Option exercise 10b5-1 | +140,000 | $4.65 | $651K | 2,404,882 |
| 2024-02-08 | Lian Brian President & CEO | Sale 10b5-1 | −60,000 | $25.95 | $1.6M | 2,344,882 |
| 2024-02-08 | Lian Brian President & CEO | Sale 10b5-1 | −80,000 | $26.95 | $2.2M | 2,264,882 |
| 2024-02-08 | Lian Brian President & CEO | Sale 10b5-1 | −40,000 | $27.45 | $1.1M | 2,224,882 |
Page 10 of 27 · 528 trades